L-ornithine-L-aspartate for hepatic encephalopathy

L-ornithine-L-aspartate for hepatic encephalopathy

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of L‐ornithine‐L‐aspartate on patients with hepatic encephalopathy.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cochrane database of systematic reviews 2017-04, Vol.2017 (4)
Hauptverfasser: Yuan, Wenming, Li, Jing, Xu, Lin, Zhang, Mingming, Lu, Zhenchan, Feng, Shejun, Wang, Ling
Format: Artikel
Sprache:eng
Schlagworte:
Medicine General & Introductory Medical Sciences
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page
container_title Cochrane database of systematic reviews
container_volume 2017
creator Yuan, Wenming
Li, Jing
Xu, Lin
Zhang, Mingming
Lu, Zhenchan
Feng, Shejun
Wang, Ling
description This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of L‐ornithine‐L‐aspartate on patients with hepatic encephalopathy.
doi_str_mv 10.1002/14651858.CD007344.pub2
format Article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6478143</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_6478143</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2202-d49dd6aa010c16309b392fbdfc547ade4216437ca03cf66025e5f487b9ef3343</originalsourceid><addsrcrecordid>eNpVkNtKw0AQhhdRsFZfQfoCG2cP2SQ3gkStQsCb3i-TPZhImg2bKPTtTagVvZoZPv4P5ifklkHCAPgdkypleZon5SNAJqRMhs-an5HVAuhCzv_sl-RqHD8AhCp4tiK8oiH27dS0vaMVxXHAOOHkNj7ETeMGnFqzcb1xQ4NdmM_mcE0uPHaju_mZa7J7ftqVL7R6276WDxU1nAOnVhbWKkRgYJgSUNSi4L623qQyQ-skZ0qKzCAI45UCnrrUyzyrC-eFkGJN7o_a-Zu9s8b1U8ROD7HdYzzogK3-T_q20e_hSyuZ5UyKWaCOAhPDOEbnf7MM9NKcPjWnT80tRi6-AawxY84</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>L-ornithine-L-aspartate for hepatic encephalopathy</title><source>Cochrane Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Yuan, Wenming ; Li, Jing ; Xu, Lin ; Zhang, Mingming ; Lu, Zhenchan ; Feng, Shejun ; Wang, Ling</creator><creatorcontrib>Yuan, Wenming ; Li, Jing ; Xu, Lin ; Zhang, Mingming ; Lu, Zhenchan ; Feng, Shejun ; Wang, Ling</creatorcontrib><description>This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of L‐ornithine‐L‐aspartate on patients with hepatic encephalopathy.</description><identifier>ISSN: 1465-1858</identifier><identifier>EISSN: 1465-1858</identifier><identifier>EISSN: 1469-493X</identifier><identifier>DOI: 10.1002/14651858.CD007344.pub2</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Medicine General &amp; Introductory Medical Sciences</subject><ispartof>Cochrane database of systematic reviews, 2017-04, Vol.2017 (4)</ispartof><rights>Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd. 2017 The Cochrane Collaboration</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2202-d49dd6aa010c16309b392fbdfc547ade4216437ca03cf66025e5f487b9ef3343</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids></links><search><creatorcontrib>Yuan, Wenming</creatorcontrib><creatorcontrib>Li, Jing</creatorcontrib><creatorcontrib>Xu, Lin</creatorcontrib><creatorcontrib>Zhang, Mingming</creatorcontrib><creatorcontrib>Lu, Zhenchan</creatorcontrib><creatorcontrib>Feng, Shejun</creatorcontrib><creatorcontrib>Wang, Ling</creatorcontrib><title>L-ornithine-L-aspartate for hepatic encephalopathy</title><title>Cochrane database of systematic reviews</title><description>This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of L‐ornithine‐L‐aspartate on patients with hepatic encephalopathy.</description><subject>Medicine General &amp; Introductory Medical Sciences</subject><issn>1465-1858</issn><issn>1465-1858</issn><issn>1469-493X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVkNtKw0AQhhdRsFZfQfoCG2cP2SQ3gkStQsCb3i-TPZhImg2bKPTtTagVvZoZPv4P5ifklkHCAPgdkypleZon5SNAJqRMhs-an5HVAuhCzv_sl-RqHD8AhCp4tiK8oiH27dS0vaMVxXHAOOHkNj7ETeMGnFqzcb1xQ4NdmM_mcE0uPHaju_mZa7J7ftqVL7R6276WDxU1nAOnVhbWKkRgYJgSUNSi4L623qQyQ-skZ0qKzCAI45UCnrrUyzyrC-eFkGJN7o_a-Zu9s8b1U8ROD7HdYzzogK3-T_q20e_hSyuZ5UyKWaCOAhPDOEbnf7MM9NKcPjWnT80tRi6-AawxY84</recordid><startdate>20170428</startdate><enddate>20170428</enddate><creator>Yuan, Wenming</creator><creator>Li, Jing</creator><creator>Xu, Lin</creator><creator>Zhang, Mingming</creator><creator>Lu, Zhenchan</creator><creator>Feng, Shejun</creator><creator>Wang, Ling</creator><general>John Wiley &amp; Sons, Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20170428</creationdate><title>L-ornithine-L-aspartate for hepatic encephalopathy</title><author>Yuan, Wenming ; Li, Jing ; Xu, Lin ; Zhang, Mingming ; Lu, Zhenchan ; Feng, Shejun ; Wang, Ling</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2202-d49dd6aa010c16309b392fbdfc547ade4216437ca03cf66025e5f487b9ef3343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Medicine General &amp; Introductory Medical Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yuan, Wenming</creatorcontrib><creatorcontrib>Li, Jing</creatorcontrib><creatorcontrib>Xu, Lin</creatorcontrib><creatorcontrib>Zhang, Mingming</creatorcontrib><creatorcontrib>Lu, Zhenchan</creatorcontrib><creatorcontrib>Feng, Shejun</creatorcontrib><creatorcontrib>Wang, Ling</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cochrane database of systematic reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yuan, Wenming</au><au>Li, Jing</au><au>Xu, Lin</au><au>Zhang, Mingming</au><au>Lu, Zhenchan</au><au>Feng, Shejun</au><au>Wang, Ling</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>L-ornithine-L-aspartate for hepatic encephalopathy</atitle><jtitle>Cochrane database of systematic reviews</jtitle><date>2017-04-28</date><risdate>2017</risdate><volume>2017</volume><issue>4</issue><issn>1465-1858</issn><eissn>1465-1858</eissn><eissn>1469-493X</eissn><abstract>This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of L‐ornithine‐L‐aspartate on patients with hepatic encephalopathy.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><doi>10.1002/14651858.CD007344.pub2</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1465-1858
ispartof Cochrane database of systematic reviews, 2017-04, Vol.2017 (4)
issn 1465-1858
1465-1858
1469-493X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6478143
source Cochrane Library; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Medicine General & Introductory Medical Sciences
title L-ornithine-L-aspartate for hepatic encephalopathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T08%3A16%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=L-ornithine-L-aspartate%20for%20hepatic%20encephalopathy&rft.jtitle=Cochrane%20database%20of%20systematic%20reviews&rft.au=Yuan,%20Wenming&rft.date=2017-04-28&rft.volume=2017&rft.issue=4&rft.issn=1465-1858&rft.eissn=1465-1858&rft_id=info:doi/10.1002/14651858.CD007344.pub2&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_6478143%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true